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Vitamin D deficiency is common in athletes. The conventional measurement of vitamin D 
levels provides a general indicator of body stores. However, there are nuances in its 
interpretation as values of 25(OH)D do not correlate absolutely with the amount of 
‘bioavailable’ vitamin to the cells. Vitamin D should be regarded as a hormone and 
influences between 5-10% of our total genome. Determining the precise effect of the 
vitamin, isolated from the actions of other co-factors, is not straightforward and restricts 
our complete understanding of all of its actions. Deficiency has harmful effects on not only 
bone and muscle but wider areas including immunity, respiratory and neurological activity. 
More caution should be applied regarding the ability of supra-normal vitamin D levels to 
elevate athletic performance. Hopefully, future research will shed more light on optimal 
levels of vitamin D and supplementation regimes, and improved understanding of its intra-
cellular control of our genetic mechanisms and how extrinsic influences modify its activity. 
INTRODUCTION 
Much attention has been paid to the global problem of hypovitaminosis D. Over one billion 
people are estimated to be deficient. In sports science and medicine and orthopaedic surgery, 
the effect of hypovitaminosis D on athletes during training and performance, and with regard 
to avoidance of injury and recovery from treatments, including surgery, has been 
investigated. 
This review will look at the sources of vitamin D, its actions and the sources of 
supplementation. It will investigate the implications for sporting performance, the evidence 
for hypovitaminosis D in causing injury, whether there are advantages in supplementation, 
and the potential implications for recovery from injury and surgery.  
Most research on hypovitaminosis D has not been undertaken on the young, fit and healthy. 
Many publications are small cohort studies lacking the highest scientific vigour. They indicate 
potential associations rather than causation. The background to many injuries and illnesses 
are multifactorial. Hypovitaminosis D may be only one of many contributors.  
Finally, one must consider what is meant by the term ‘athlete’. Different sports vary in their 
cardiovascular, respiratory, musculoskeletal and neurological requirements. The elite athlete 
frequently displays extraordinary anatomy, physiology and genetic advantages. The ‘weekend 
warrior’ comes from a wide age-band with less imposing intrinsic credentials. However, all 
are at risk.  
VITAMIN D STATUS IN THE ATHLETE AND PRE-OPERATIVE PATIENT 
Many sports have been investigated with high numbers of athletes found to have 
hypovitaminosis D. Dark skin tones, participation in indoor sports, and living in higher 
latitudes are prominent risk factors. There are no large population studies directly comparing 
vitamin D levels in the athletes with more sedentary groups in the same society. 
The prevalence of hypovitaminosis D in pre-operative orthopaedic patients mirrors the 
general population. Risk factors include trauma, sports-related surgery, the young, excessive 
 






sunscreen use, males, and surgery during winter months 1,2. These trends have been 
confirmed in shoulder 3 and foot and ankle surgical patients 2,4,5.  
VITAMIN D PHYSIOLOGY 
Conversion of Vitamin D 
The processes for vitamin D conversion from its cutaneous and dietary precursors to the 
active metabolite and subsequent activity is shown in Figure 1. 
25(OH)D, or calcidiol, is the inactive form of vitamin D and has a half-life of 21-30 days. A 
request for vitamin D estimation normally results in a measurement of this inactive 
metabolite. 25(OH)D represents a general indicator of body vitamin D stores. As a fat-soluble 
vitamin, it is stored in adipose tissue. Fluctuations in its levels are both an indicator of dietary 
intake and seasonal changes that affect cutaneous synthesis.  
25(OH)D undergoes a second hydroxylation to produce the active metabolite, 1,25(OH)D, or 
calcitriol. The enzyme responsible is 1 α-hydroxylase (CYP27B1). CYP27B1 is found in many 
tissues. Its serum half-life is between 4-15 hours. 1,25(OH)D laboratory estimation is usually 
more involved and expensive. The less active metabolite 24,25(OH)D is formed in the kidneys. 
Carriage of Vitamin D 
Figure 2 shows how vitamin D is carried in the circulation. 
The ‘free hormone hypothesis’ theorises that only unbound 1,25(OH)D can enter cells and 
exert influence but there is evidence that some tissues admit 1,25(OH)D bound to the vitamin 
D binding protein (VDBP). The levels and activities of VDBP influence vitamin D bioavailability 
to all tissues. This can alter the balance between free and bound vitamin D fractions. In such 
circumstances, the measurement of the total 25(OH)D3 levels may be misleading. ‘Free’ 
vitamin D measurements are not routinely available in clinical practice. 
In black and Hispanic men, studies in both normal and athletic populations have reported high 
incidences of hypovitaminosis D 1,6. However, the same groups have a lower risk of 
osteoporosis and fractures.  The close relationship between vitamin D levels and bone mineral 
density (BMD) is clearer in lighter than darker skin tones 7.  The ability of black subjects to 
function at reduced vitamin D levels may be related to genetic variations in VDBP affecting 
the bioavailability of the vitamin 8. 
Vitamin D receptors 
Vitamin D receptors (VDRs) are found in most tissues and organs including the skin, placenta, 
bone, prostate, lung, breast, colon, pancreatic β cells, monocytes, lymphocytes, parathyroid 
glands, granuloma tissue 9. 1,25(OH)D3 has been found to influence the activities of up to 5-
10% of our total genome 10. Figure 3 outlines the role of VDR activity. VDR expression declines 
with age and may play a part in the natural decline of sporting performance 11. 
Calcidiol (25(OH)D), calcitriol (1,25(OH)D) and ‘deficiency’ 
 






The major circulating metabolite is the inactive form, 25(OH)D, and is measured in nmol/L (or 
ng/ml). The biologically active form, 1,25(OH)D, is present in much smaller amounts and is 
measured in pmol/L (or pg/ml). The relationship between the two is not precise. Conventional 
wisdom suggests that 25(OH)D levels have to fall to <20nmol/L to cause a significant reduction 
in 1,25(OH)D. Even at levels of 25(OH)D below 40nmol/L, Parathyroid hormone (PTH) levels 
rise and stimulates 1,25(OH)D production. This preserves intestinal calcium absorption 10.  
An Italian study found 17% of patients had serum 25(OH)D3 levels <25nmol/L - indicating 
severe deficiency. However, only 3% were severely deficient in 1,25(OH)D with levels 
<18pg/ml. It reported that low to moderate deficiencies of 25(OH)D were not necessarily 
associated with mineral homeostasis disorders but may have elevated PTH levels 12. Severe 
deficiency was rarer for 1,25(OH)D and could be associated with normal levels of 25(OH)D. 
Severe deficiency of 1,25(OH)D is more likely to be associated with reduced levels of serum 
and urinary calcium. 
This potential dissociation between the two metabolites should be considered when 
counselling patients. The relationship is multifactorial involving renal and parathyroid 
function and VDBP and albumin levels and activity. 
25(OH)D may be regarded as a reasonable and relatively cheap primary screening tool of 
vitamin D reserves.  However, suspected mineral homeostasis disorders in the athlete require 
a more detailed analysis. This should include measurements of serum 1,25(OH)D, the 
bioavailable ‘free’ concentrations, serum PTH, serum calcium and phosphorus, and urinary 
calcium. In the future, genotyping of important stages in the delivery of vitamin D to the cells, 
such as VDBP variations, will enhance our understanding of the ‘vitamin D status’ of our 
athletes. 
VITAMIN D ACTIVITY 
1,25(OH)D can be considered to have both endocrine activity and autocrine/paracrine 
activities 10. The substrate should not be regarded as a vitamin but a secosteroid hormone. 
The different pathways and location of various endocrine and autocrine/paracrine activity are 
shown in Figure 4. 
WHAT IS A NORMAL VITAMIN D LEVEL? 
There is no consensus for what constitutes normal serum vitamin D levels. Normal status 
should reflect the levels when the vitamin functions effectively at its target sites. This should 
include optimal benefits to bone, muscle, and all the other tissues and organs that host a VDR. 
The level should not excessively stimulate PTH causing secondary hyperparathyroidism. It is 
unlikely that one level of Vitamin D reflects all of these aims.  
An athlete’s vitamin D status can be regarded as deficient, insufficient or replete (normal). 
Figure 5 reflects how professional groups, researchers and various sporting organisations 
have defined reasonable levels to address issues of bone health, muscle function and 
immunity and infection defence 13-19. 
 






VITAMIN D AND BONE HEALTH 
Bone is a very active tissue. It grows during childhood and repairs following fractures. It 
undergoes constant structural repairs, has haemopoietic activity, and responds to the 
presence or absence of mechanical stimuli. Its health is dependent upon the interaction 
between multiple intrinsic and extrinsic factors, including those determining vitamin D status. 
The knowledge that severe vitamin D deficiencies can produce rickets in children and 
osteomalacia in adults confirms vitamin D’s importance for bone health. However, the link is 
not simple. Recent animal and human work suggest that vitamin D has both endocrine and 
autocrine/paracrine activities which influence bone health. 
Rat experiments have examined the influence of restricting dietary vitamin D and calcium on 
bone structure and activity. Osteomalacia occurred when only both vitamin D and dietary 
calcium were severely restricted 20,21. When 25(OH)D levels are <20nmol/L, 1,25(OH)D levels 
began to fall and hence calcium intestinal absorption. Severe reduction of 1,25(OH)D, by 
experimental ablation of the genes responsible for VDRs or 1-α hydroxylase enzymes 
(CYP27B1), diminishes intestinal absorption of calcium and phosphate. However, the 
development of osteomalacia can be overcome with high dietary calcium and phosphate 22. 
Conversely, in animal studies, osteoporosis could occur when either vitamin D or dietary 
calcium were deficient individually 20,21. Clinically, the risk of non-vertebral fractures does not 
fall until 25(OH)D levels are >80nmol/L 23. In animal studies, maximum bone structure and 
strength occurred at 25(OH)D levels >80-100nmol/L combined with adequate calcium intake 
24. Rat and human serum vitamin D levels appear similar. 
It appears that bone health is affected by more than the endocrine actions of vitamin D, since 
25(OH)D levels >20nmol/L are likely to maintain endocrine activities. Vitamin D influence on 
bone does not appear to be VDR activation related – which occurs only at extremely high 
levels of 25(OH)D in experimental animals 25. The effect appears mediated by the autocrine 
conversion of 25(OH)D to 1,25(OH)D within bone cells.  
In vitro evidence suggests that osteoclast activity is reduced at 25(OH)D levels >80nmol/L and 
osteoblasts and osteocytes are stimulated to accelerate maturation and mineralisation by 
rising levels of 1,25(OH)D. Furthermore, increased dietary calcium appears to act as more 
than a structural asset for bone production. In animal studies, it upregulates 1α-hydroxylase 
activity within bone cells and encourages mineralisation. Theories on how increased levels of 
1,25(OH)D affects osteoblast function are multiple. These include bone modelling signalling 
mechanisms, phosphate homeostasis, and enhancing the response to mechanical loading. 
Does Vitamin D status affect peak bone mass in athletes? 
Peak bone mass is achieved in late teens and early twenties shortly after peak height 
attainment 26,27. After that bone mass plateaus and then gradually declines. This reduction 
accelerates for the female in the post-menopausal period. Failure to reach acceptable peak 
bone mass can have ramifications for the rest of an individual’s life - particularly for fracture 
risk. These changes are depicted in Figure 6. 
 






The strength of evidence supporting the effect of lifestyle factors on bone mass has been 
considered 27. Level A (strong evidence) factors included the effect of physical activity on bone 
mass and density, and adequate dietary calcium. Level B (moderate evidence) factors 
included the effect of exercise on bone structure, adequate vitamin D levels, and the inclusion 
of dietary dairy products. At the same moderate evidence level, contraceptive injections (e.g. 
Depo-Provera) have an adverse effect.  
At lesser evidence levels, the beneficial effects of dietary fat, protein, fruit, vegetables and 
fibre have been examined as well as breast feeding. Similarly, the detrimental effects of 
carbonated drinks, caffeine, alcohol, cigarettes, oral contraceptives have been reported. 
For females, another factor has both genetic and modifiable influences. The age of menarche 
can affect later peak bone mass. For many young females, the menarche can be delayed in 
part by certain physical activities. Long-distance runners, dancers and triathletes fall into this 
category. In females with a delayed menarche, low bone mineral density has been 
demonstrated even in the pre-pubertal period 28. Longitudinal studies have demonstrated a 
close association between the age of menarche and the age at peak bone mineral content 
velocity (PBMCV) 29 and ultimate bone mass in young adults 30. Late onset menarche is 
associated with weakened bone structure and reduced mechanical resistance. Not only does 
this increase fracture risk in adulthood but also in adolescence 31. 
The advice to young athletes to sensibly supplement with vitamin D would appear reasonable. 
However, its influence on eventual peak bone mass may be only marginal. The adoption of 
the many lifestyle choices mentioned above should be combined to maximise bone strength. 
Athletes involved in repetitive high-impact activities do improve bone mineral density (BMD). 
This might help to offset naturally low 25(OH)D levels and partially explain the oft-observed 
lack of direct correlation between vitamin status and measurements of bone health. 
However, limbs that are not involved in such activities during recreation, e.g. upper limbs 
during running or low impact sports, place the athlete at similar risks of bone pathology at 
these sites as more sedentary patients. 
Relationship between vitamin D and bone mineral density (BMD) 
The relationship between 25(OH)D serum levels and the results of BMD measurements are 
not exact. Many patients will be found to have normal BMDs but inadequate vitamin D levels 
and vice versa. This is especially true for young athletes with darker skin tones 32,33. 
Parathyroid Hormone (PTH), vitamin D metabolism and bone health 
Low blood calcium stimulates the parathyroids to release PTH and induces secondary 
hyperparathyroidism. PTH increases the renal conversion of 25(OH)D to 1,25(OH)D. This in 
turn increases intestinal calcium and phosphate absorption. There is an age-related decrease 
in calcium absorption that may contribute to secondary hyperparathyroidism.   
Low levels of 25(OH)D normally accompany low calcium levels and stimulate PTH secretion. 
Its mode of action is probably an autocrine activity. Falling 25(OH)D levels reduce the 
 






conversion to 1,25(OH)D in the parathyroid cells. The active vitamin within the cell regulates 
PTH secretion. As levels fall, increasing amounts of PTH are released 10. 
Bone and kidneys have PTH receptors. If inadequate calcium is absorbed from the gut, 
1,25(OH)D and PTH, together (acting via their receptors) release calcium from the bone stores 
and increase calcium reabsorption from the renal distal convoluted tubules. 
The rationale for the use of vitamin D and calcium in protecting bone from injury is via its 
suppression of PTH levels. PTH (via its receptors) stimulates osteoclastic activity and releases 
calcium. This increases bone turnover and decreases bone mass. 
Vitamin D levels needed to suppress PTH levels and minimise bone resorption are debated. 
Some suggest PTH levels plateau at 75nmol/L 34,35. Others describe adequate suppression at 
50nmol/L and bone metabolism markers are reported to stabilise at vitamin D levels >45 
nmol/L 36.  It is not clear what the clinical significance is of higher serum PTH when the serum 
25(OH)D levels are >50 nmol/litre in certain individuals with normal bone markers. Various 
explanations include age-related calcium absorption reduction, deteriorating renal function, 
and low calcium intake.  
Other factors influence PTH levels including race, gender, weight, serum leptin levels, and 
serum sex hormone binding globulin. These may affect the varying range of serum 25(OH)D 
levels at which serum PTH is maximally suppressed. There may also be a form of receptor 
disease whereby tissues do not respond to PTH, which can lead to elevated levels of the 
hormone. 
Functional hypoparathyroidism occurs with an inadequate PTH response to low vitamin D 
levels. Approximately 50% of people exhibit such a response. This can occur in all age groups 
37. Generally older patients tend to have higher levels of PTH for a similar Vitamin D serum 
level.  
Supplementation may not be as effective in patients with functional hypoparathyroidism. 
However, several studies have indicated that patients with a low PTH response to low 25(OH) 
levels have higher BMDs. This may bestow a protective bone health effect 37,38. 
ARE LOW VITAMIN D LEVELS ASSOCIATED WITH INCREASED INJURY RISK? 
Publications have identified an association between fractures and hypovitaminosis D. This 
have been reported in mixed trauma groups 1,39 and specific locations such as hip 40-43, pelvis 
44 and spine 45. Links with trauma, 46-48 bone marrow oedema syndrome 49 and talar 
osteochondral lesions 50-52 have been described in the foot and ankle. However, one series 
demonstrated no difference in the spectrum of vitamin D deficiency in a foot and ankle 
trauma group compared to a pre-surgical non-trauma group sampled simultaneously in the 
United Kingdom 48. 
Stress fractures are common in young, active individuals. Much research in this area has been 
undertaken in the military. The incidence in recruits has been estimated at between 0.2-5.2% 
in males and 1.6-30% for females. The economic burden can become great. Vitamin D 
 






deficiency has been associated with stress fractures in young, athletic adults in Finland, Israel, 
Britain and USA 6, 53-55. 
Within tendons, vitamin D appears to be implicated in the balance affecting extra-cellular 
matrix components. Collagen degradation is aided by upregulating MMP (matrix 
metalloproteinases), which is counterbalanced by TIMP (tissue inhibitors of 
metalloproteinases) activity. Basic science research has indicated that vitamin D plays its role 
in downregulating MMP-9 56,57. An imbalance between MMPs and TIMPs has been associated 
with active tendinopathy and large tears of the rotator cuff 58-60. 
DOES VITAMIN D SUPPLEMENTATION REDUCE INJURY RISK? 
 
In the elderly, prevention of falls research and meta-analyses have produced varying results. 
Protocols have varied in terms of serum vitamin D starting levels, duration of 
supplementation, levels of serum blood vitamin D achieved, and the amount of vitamin D 
given. Benefits have varied from none 18,61 to fall reductions between 14%-22% 11,62-64. A 
reasonable consensus from so many sources would be that the elderly should aim to maintain 
vitamin D levels in excess of 50-60nmol/L, which requires daily supplementation of 700-
1000iu/day. Vitamin D and calcium together appear to be more effective at falls reduction 
than calcium alone 65. 
A 21% reduction in stress fractures in female military recruits was reported during a 2-year 
period with calcium (2000mg) and vitamin D (800iu) supplementation66. Winter 
supplementation (2000iu/day) in a group of professional ballet dancers increased isometric 
strength and jump height and significantly reduced injuries 67. 
Vitamin D, alone or in combination with calcium supplementation, has been reported to 
reduce fracture risks in the elderly 23,68. Reduced muscle atrophy and hip fracture rates in 
post-stroke elderly females has been reported 69. However, others found that 
supplementation with calcium and vitamin D improved hip bone density but did not reduce 
fracture risk significantly 70. 
CAN VITAMIN D SUPPLEMENTATION INCREASE INJURY RISK? 
Various studies have looked at the effect on fracture risk of intermittent high dose vitamin D 
supplementation in the elderly. 
The administration of large one-off annual doses (500,000iu) in elderly females was reported 
to increase falls and hip fractures 71,72. Others found a decrease in fractures with a four-
monthly dosing-regime 73. One report demonstrated a U-shaped curve effect of vitamin D 
supplementation. Maximum fall reduction occurred at levels of 80-95nmol/L and increased 
at levels beyond 100-112.5nmol/L 74. The cause of increased falls with intermittent high doses 
and/or higher serum levels is unknown.  
 
 






POTENTIAL EFFECTS OF HYPOVITAMINOSIS D ON SURGICAL RECOVERY 
There is growing evidence that hypovitaminosis D adversely effects post-operative recovery 
for a wide range of orthopaedic procedures. However, published work has not concentrated 
on the athletic population. 
Recovery delays from anterior cruciate ligament reconstruction has been reported 75. Patients 
with 25(OH)D levels <50nmol/L had inferior outcomes 1-year after ankle fracture fixation 76. 
Bone healing after foot and ankle fusions is worse at low vitamin levels 77,78. 
Patients undergoing spinal surgery have a high prevalence of hypovitaminosis D 79 and have 
higher levels of pre- and post-operative pain, pedicle screw loosening, and revision rates. 
Fusion rates also appear to be lower 80-82. 
For lower limb arthroplasty patients, low levels have been associated with longer in-patient 
stays 83,84, more post-operative pain 85, worse outcomes at 3-months 86 and 8-years 84 and 
increased risk of periprosthetic joint infection 87. Moreover, vitamin D levels have been 
observed to fall following such surgery 88.  
Altered MMP/TIMP balance has been associated with failure of shoulder rotator cuff tears, 
which vitamin D may influence 89. Animal models have demonstrated impaired healing of 
rotator cuff tears in rats fed a vitamin D deficient diet 90. 
For surgery in general, a systematic review reported that 26 out of 31 articles identified 
statistically significant and clinically important post-operative adverse outcomes associated 
with hypovitaminosis D. These included both surgical site and hospital-acquired infections, 
organ graft failure, myocardial infarction incidence, increased cancer risk post-organ 
transplantation, ICU stay, hospital in-patient stay and any cause one-year mortality after 
surgery 91. Pre-surgical vitamin D status is the more relevant predictor of long-term outcomes 
compared to post-surgical vitamin D status, and minimal benefits are derived from 
supplementation in the peri- or post-operative period 92,93. 
WHAT EFFECT MIGHT HYPOVITAMINOSIS D HAVE ON ATHLETIC 
PERFORMANCE? 
Do low levels of Vitamin D impact on athletic performance? The evidence is mixed. Reduction 
in athletic performance in winter months and the benefits of exposure to UVB radiation have 
long been acknowledged.  
Winter supplementation for dancers improved muscle strength and reduced injury 67. A direct 
correlation between vitamin D levels and muscle power, force, velocity and jump height in 
12-14-year old girls 94 and low vitamin D levels adversely affecting bone mass and turnover, 
and muscle strength in adolescent girls have been reported 95. 
However, it could not be demonstrated that high doses of supplementation influenced 
physical performance over a 12-week period 96 and that 25(OH)D levels were not a predictor 
of athletic performance in adolescents 97. 
 
 







Bone and Joint Health 
Aspects of vitamin D status on bone health were explored earlier in this article. However, does 
it influence fracture healing? Animal studies have indicated benefits from vitamin D 
supplementation. With vitamin D’s acknowledged role in bone health, its ability to influence 
cell differentiation and neuromuscular function, its role in inflammation and findings 
suggesting that deficiency is associated with re-fracture and delayed bone healing, it seems 
reasonable to conclude that maintaining vitamin D levels will help fracture healing. A 
systematic review of 114 papers in human fracture healing concluded that vitamin D 
appeared to have a role, but the precise mechanism was not clear 98.  
Does the maintenance of vitamin D levels influence the later development of osteoarthritis in 
athletes?  A systematic review found no link between vitamin D and hip or hand osteoarthritis 
but some evidence within the knee joint 99. The need for RCTs to establish if supplementation 
can slow knee OA progression is required. 
High BMI 
High BMI levels are seen in certain sports. Obesity is associated with hypovitaminosis D and 
elevated PTH levels. Higher body mass index (BMI) individuals might spend less time exposed 
to ultraviolet B rays (UVB). Vitamin D is a fat-soluble vitamin stored within adipose tissues 
which reduce its bioavailability. Raised BMI is associated with a reduced response to UVB 
exposure and vitamin D oral supplementation. Both cutaneous and oral sources are 
sequestrated in large fat reservoirs. This needs to be considered when advising on 
supplementation.  
Obesity is a chronic, low-grade inflammatory state. The tissues produce adipokines and 
macrophages that are proinflammatory. These proteins levels are influenced by BMI and 
vitamin D status. Hypovitaminosis D raises blood levels of such adipokines, e.g. TNF-α, CRP 
and IL-6. It appears that vitamin D acts as an anti-inflammatory and immuno-regulator. 
Skeletal Muscle 
The effect of vitamin D deficiency on skeletal muscle is well documented. Osteomalacia is 
associated with a marked proximal myopathy. Skeletal muscle biopsies reveal predominantly 
Type II muscle fibre change with atrophy, fat infiltration and fibrosis – an effect that can be 
reversed with vitamin D and calcium supplementation. 
Vitamin D promotes skeletal activity in several ways. VDR activity promotes protein 
production. Additionally, it exerts its influence through signalling cascades promoting cell 
proliferation and differentiation 9(11). It regulates intracellular phosphate levels in muscle cells. 
In animal studies, vitamin D deficiency associated with hypocalcaemia did not produce muscle 
weakness, whereas hypovitaminosis D and hypophosphatemia caused profound but 
reversible changes 100. 
Most research in this area has concentrated upon the elderly with regards to falls. Many 
elderly people develop progressive motor deficiencies that may be responsive to the positive 
 







effects of supplementation. Indeed, VDR expression in muscle decreases with age 
contributing to a decline in sporting performance.  
What relevance might this have to athletes training to develop adaptive responses to 
promote repair and remodelling of muscle following purposeful damaging eccentric exercise? 
Younger athletes would be expected to have stronger muscle function with less margin for 
improvement. However, elevating vitamin D levels to greater than 75nmol/L has been shown 
to enhance recovery, remodelling and adaptation following intense exercise 101. 
Supplementing with both vitamin D and calcium can increase type IIA (fast twitch) muscle 
fibres 102 and 1,25(OH)D is important in muscle recruitment by directing appropriate 
precursor cell differentiation 101. 
Immune Response, Inflammation and Infection 
Athletes often develop chronic fatigue. Additionally, they are prone to recurrent infections. 
Careful investigation frequently reveals underlying conditions, including deficient humoral 
immunity, allergies and asthma. 
The VDR is found in cells involved in the immune response including T- and B-lymphocytes, 
monocytes, macrophages and neutrophils. Not only will these cells respond to circulating 
levels of vitamin D but are also capable of synthesizing 1,25(OH)D themselves. As such vitamin 
D exerts an autocrine action within such cells. Vitamin D can affect both the adaptive and 
innate immune response and deficiency can be associated with increased infection risk and 
the development of auto-immune disorders 103.  The ability of Vitamin D to coordinate the 
innate and adaptive arms of immunity has been found to be important in fighting diseases 
such as tuberculosis. 
Vitamin D aids antimicrobial activity and VDBP helps Vitamin D bioavailability in addition to 
its own separate supportive cellular-level roles. A single, large dose of vitamin D has been 
shown to improve innate immunity 104. Its effect upon the respiratory system will be discussed 
in the next section.  
A link has been established between low vitamin D levels and the elevated biomarkers of 
inflammation found in runners 105. The implications are not clear. TNF-α acts as a trigger for 
tissue repair and regeneration but is hypothesized to play a part in over-training syndrome, 
injury risk and immune suppression. 
Pulmonary Health 
Adequate vitamin D and VDBP levels are required for healthy pulmonary function. Various 
respiratory diseases have been associated with hypovitaminosis D including asthma, infection 
and chronic obstructive pulmonary disease (COPD). College athletes with low vitamin D levels 
are more likely to develop acute upper respiratory infections106. 
Maintaining winter vitamin D levels greater than 95nmol/L is reported to protect against viral 
infections. Below 95 nmol/L, the risk of developing upper respiratory tract infections (URTIs) 
doubled 107. Others have reported that maintaining levels at greater than 75nmol/L in athletes 
 







prevents URTIs and enhances immunity 108, supplementation at 4000iu/day reduced RTI in 
high risk patients 109 and maintaining adequate vitamin D levels reduces the prevalence of 
Influenza A 110. There is some early evidence that low vitamin D levels might be associated 
with greater mortality from COVID-19 111. 
Athletes have a higher incidence of asthma and allergic rhinitis than the normal population. 
Low levels of Vitamin D are associated with increased levels of eosinophils and IgE as well as 
an increase in hospital admissions and increased severity of asthma in both adults and 
children 108. Screening susceptible athletes and supplementing with Vitamin D may reduce 
asthma exacerbations and secondary URTIs. 
Thyroid disease 
Both under- and over-activity of the thyroid can affect athletic performance. Associations 
between low vitamin D status and thyroid disease have been reported, particularly in the area 
of auto-immune diseases such as Hashimoto’s thyroiditis. However, any causal relationship 
remains unresolved. 
Diabetes Mellitus 
Improved monitoring and control of diabetes has allowed sufferers to increasingly engage in 
sport – even at the highest level. Studies have shown that patients recently diagnosed with 
type 1 diabetes have reduced level of vitamin D. However, regular doses of vitamin D from a 
young age appears to reduce the risk of developing type I diabetes. Moreover, maintaining 
adequate levels of vitamin D appears to improve glycaemic control and insulin sensitivity in 
type I and II diabetics and in normal individuals. 
Low levels of 25(OH)D have been found to be independently associated with insulin sensitivity 
and beta-cell function in patients at risk of type 2 diabetes 112 and it has been shown that 
patients with 25(OH)D levels below 75nmol/L were five times more likely to develop type II 
diabetes 113. Additionally, hypovitaminosis D has been shown to be a possible risk factor for 
developing diabetic foot ulcers within the diabetic population 114,115. 
Cardiovascular 
As a result of intense athletic training (particularly in those sports requiring intense amounts 
of running), the cardiovascular system can undergo profound adaptive change that allows 
improved performance. These changes involve both electrophysiological and structural 
change. Indeed, the hypertrophic and ECG changes of the athletic heart can mimic pathology 
rather than evidence of a superbly adapted organ.  
Whilst large studies on the effects of low vitamin D levels on cardiovascular disease have been 
published and those findings remain debated, the effects of variations in vitamin D status 
upon the athletic heart remains less well-researched.  
Animal and human studies have demonstrated adverse effects on cardiac structure and 
function with vitamin D deficiency in the general population. Reduced hypertrophic changes 
 







have been observed in athlete’s hearts following training when vitamin D stores have been 
depleted 116,117. 
 
Neurological disorders and pain perception 
Athletes require highly developed neurological conditioning including balance, coordination 
and reflex responses. Additionally, many require an ability to tolerate pain without detriment 
to performance. 
1,25(OH)D has an important role in both the central and peripheral nervous systems and is 
active in brain development and function. It is involved in myelin formation and 
differentiation, axonal distribution and homogeneity of peripheral nerves, and neuronal stem 
cell and myogenic differentiation. Vitamin D has been linked to several neurological disorders 
although its precise role requires further research 118,119. In animal studies, mice deficient in 
VDR had decreased balance (vestibular) function 120. 
93% of patients presenting with resistant non-specific musculoskeletal pain had Vitamin D 
levels below 50nmol/L 121. They reported that young women were most at risk of delayed or 
misdiagnosis. Pain may be a strong feature of rickets osteomalacia and vitamin D induced 
myopathy 122.  
Fatigue, Anxiety, Depression and Suicide 
Most athletes will experience bouts of fatigue and anxiety during intense training and 
competition. At times, particularly during periods of prolonged recovery from injury, some 
will become depressed. 
A direct link has been described between elderly subjects and fatigue as defined by reduced 
energy levels, muscle strength and cognitive activity 123. 
The relationship between anxiety, depression, suicide and low vitamin D levels has been 
extensively investigated. Some researchers have found a positive correlation between 
depression and low vitamin D levels 124-126. 
In a large Danish cohort, no link could be found between anxiety, depression and low vitamin 
levels 127. US military personnel with vitamin D levels below 40nmol/L were reported to have 
an increased risk of suicide 128. A possible association between seasonal affective disorder and 
low vitamin D has been reported 129. 
VITAMIN D SUPPLEMENTATION 
The decision to advise any athlete to supplement with vitamin D should be carefully 
considered. Is the vitamin D being prescribed to elevate serum levels to ‘normal’ range? 
Alternatively, is it being given to boost levels from adequate to supra-normal in the belief that 
such status prefers some form of ergogenic (performance enhancing) aid to the athlete? 
Figure 7 outlines the management pathway. 
 








Dietary Sources of Vitamin D 
Vitamin D can be found in a range of dietary products. These include oily fish, such as salmon, 
tuna, sardines, herring, and mackerel, and egg yolks, cod liver oil and cheeses. Some foods 
are fortified with vitamin D including breakfast cereals, certain dairy products, orange juice 
and soy milk. 
How much Vitamin D should the athlete take? 
Various sports have published their supplementing algorithms. It should be recognised that 
within each regime, individuals’ responses to similar dosage can vary greatly. Inevitably such 
tables are based on expert opinion rather than irrefutable objective data. A suggested scheme 
for supplementation is shown in Figure 8. 
The main decision is whether to start with a loading regime or commence immediately with 
a maintenance dose. The decision should be based upon the initial vitamin D levels, evidence 
for adverse effects from the deficiency, the speed with which adequate vitamin D levels need 
to be reached, and the presence of any medical co-morbidities that warrant a cautious 
elevation of levels. 
If a 300,000iu bolus is given with no follow up supplementation, it will last about three months 
assuming normal metabolic activity. It is advised to re-estimate blood levels at this stage and 
then administer a maintenance dose. It has been reported that 2-monthly boluses of 
100,000iu will maintain levels above 75nmol/L in subjects with moderate baseline levels (50-
75nmol/L). A maximum response at 7 days was noted. Younger patients had a more positive 
initial response and a sharper decline. Potential reasons for a more blunted response with 
age were a greater BMI and a lower hepatic 25-hydroxylase capacity 130. 
What type of Vitamin D should the athlete take? 
Cholecalciferol (D3) is preferable to ergocalciferol (D2) 19. It is reported that vitamin D2 is 
much less effective than D3 in achieving desired serum levels 131. 
Vitamin D alone or combined with calcium supplements? 
The recommended daily allowance (RDA) for calcium is 1300mg for adolescents and 
between 1000-1200mg for adults. Once daily intake regularly exceeds 2000mg, the risks of 
harm increase 17, including cardiovascular disease and an increase in renal calculi. Calcium 
addition to vitamin D supplementation appears to improve longevity 132 and decrease in 
fracture risk in the elderly has been reported 133. 
Monitoring of Vitamin D levels in the Athlete 
When to measure an athlete’s vitamin D blood levels depends upon whether it is for screening 
purposes or to monitor the response to supplementation. 
Athletes advised to embark upon vitamin D supplementation should have their serum levels 
measured prior to commencement. 
 







For a patient taking the same daily or weekly dosage, an enhanced steady state of serum 
vitamin D levels will be obtained between 3 and 6 months. Therefore, under normal 
circumstances, repeat testing is not necessary before this period 18. 
There are circumstances when an earlier repeat analysis might be deemed necessary. This 
would include a high initial loading dose or symptoms suggestive of vitamin D toxicity. It 
allows the patient’s initial response to be monitored and subsequent dosage adjusted 
accordingly. However, a change of between 31-40% between serial measurements needs to 
be recorded to confirm that the observed difference is more than a combination of analytical 
and natural biological variability 134. 
All clinicians prescribing vitamin D supplementation should be aware that it can unmask 
previously undiagnosed primary hyperparathyroidism (PHPT) – particularly if taken with 
calcium supplementation. PHPT is present in about 0.01% of the population. If high PTH levels 
are noted with vitamin D depletion, the levels should fall with vitamin supplementation. If 
not, PHPT should be suspected. While vitamin D repletion (in the presence of PHPT) helps 
bone mass restoration, it can increase the risk of hypercalcaemia. 
Vitamin D Toxicity 
Normal cutaneous vitamin D synthesis is self-regulating with increased melanin synthesis 
being one regulatory mechanism. However, excessive oral intake can in rare circumstances 
lead to toxicity. Serious consequences are mediated via hypercalcaemia leading to cardiac, 
renal and soft-tissue damage. Symptoms might include varying symptoms of malaise, 
abdominal pain, confusion, constipation, itching, weakness, thirst, fever, and chills. Other 
complications occur via increased urinary excretion of calcium.  
Hypercalcaemia does not usually occur until vitamin D levels approach 250nmol/L 135. 
However, some authorities caution on serum levels greater than 180nmol/L 18.  
A daily dose of ≤10,000iu/day in the short-term is not associated with toxicity. Above these 
dosages, the duration of supplementation is important. In general, dosages of >50,000iu for 
longer than one-month risks hypercalcaemia18.  
Long-term intake of 4000iu/day has been advised as safe for most adults and children over 
11 years of age, including pregnant and lactating women 18. However, advice for people with 
co-morbidities predisposing to hypercalcaemia should be more restricted.  
The body attempts to control high doses of vitamin D by converting more substrate to 
24,25(OH)D, which adversely effects 1,25(OH)D signalling and reduces 25(OH)D conversion to 
1,25(OH)D. One study found that after stopping high dose supplementation in athletes 
(70,000iu/week), levels of 24,25(OH)D levels remained elevated after 25(OH)D and 1,25(OH)D 
levels began to fall 136. This might have a counterproductive effect on vitamin D activity and 












The need for vitamin D throughout the body is well-established. Equally the presence of 
hypovitaminosis D in many athletes is acknowledged. Its importance and ubiquity require it 
to be considered a hormone rather than a vitamin. However, it functions in part of a 
multifactorial milieu that affects such elements as bone and muscle function, immunity, 
inflammation and respiratory function, which are so vital for athletic performance, protection 
from injury and disability, and recovery from bone and soft-tissue damage. Consequently, the 
exact relationship between vitamin D and elements like bone density and muscle strength is 
hard to isolate. The advisability of maintaining vitamin D levels at 75-100nmol/L for optimal 
functioning during normal life and sport seems obvious. However, the evidence for 
maintaining vitamin D levels at supra-normal levels (i.e. >100-125nmol/L) to boost athletic 
performance is less clear. 
Future research should concentrate on understanding how the amounts of ‘bioavailable 
vitamin D’ can be optimised, improving our knowledge on the autocrine and paracrine 
activities of the vitamin, and how genetic and epigenetic factors like training, ageing and diet 
might alter vitamin activity. 
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Figure 1. Calcium homeostasis and Vitamin D conversion 
Figure 2. Vitamin D carriage in circulation 
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Figure 4. Endocrine and Autocrine/Paracrine activity of vitamin D 
Figure 5. What is a normal vitamin D level? 
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Figure 7: Vitamin D deficiency management 
Figure 8. Vitamin D supplementation regime for the athlete  
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